Cargando…

The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC

BACKGROUND: Neuroendocrine prostate cancer (NEPC) is often diagnosed as a sub‐type from the castration‐resistant prostate cancer (CRPC) recurred from the second generation of anti‐androgen treatment and is a rapidly progressive fatal disease. The molecular mechanisms underlying the trans‐differentia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Cheng‐Fan, Chen, Yu‐An, Hernandez, Elizabeth, Pong, Rey‐Chen, Ma, Shihong, Hofstad, Mia, Kapur, Payal, Zhau, Haiyen, Chung, Leland WK, Lai, Chih‐Ho, Lin, Ho, Lee, Ming‐Shyue, Raj, Ganesh V, Hsieh, Jer‐Tsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8858611/ https://www.ncbi.nlm.nih.gov/pubmed/35184376 http://dx.doi.org/10.1002/ctm2.695

Ejemplares similares

Reciprocal deregulation of NKX3.1 and AURKA axis in castration-resistant prostate cancer and NEPC models
por: Sooreshjani, Moloud Aflaki, et al.
Publicado: (2021)

The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer
por: Lo, U‐Ging, et al.
Publicado: (2022)

Validation of SV2A-Targeted PET Imaging for Noninvasive Assessment of Neuroendocrine Differentiation in Prostate Cancer
por: Guan, Bing, et al.
Publicado: (2021)

Cancer cell’s neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction
por: Yin, Liyuan, et al.
Publicado: (2020)

Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer
por: Stewart, Paul A., et al.
Publicado: (2017)

Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics
por: Chu, Gina Chia-Yi, et al.
Publicado: (2019)

The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression
por: Lo, U-Ging, et al.
Publicado: (2017)

Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells
por: Zhang, Shumin, et al.
Publicado: (2010)

The roles and mechanism of IFIT5 in bladder cancer epithelial–mesenchymal transition and progression
por: Huang, Jun, et al.
Publicado: (2019)

SRC family kinase FYN promotes the neuroendocrine phenotype and visceral metastasis in advanced prostate cancer
por: Gururajan, Murali, et al.
Publicado: (2015)

Preface
por: Hsieh, Jer-Tsong, et al.
Publicado: (2013)

A Theranostic Small-Molecule Prodrug Conjugate for Neuroendocrine Prostate Cancer
por: Gonzalez, Paulina, et al.
Publicado: (2023)

Matched pairs of human prostate stromal cells display differential tropic effects on LNCaP prostate cancer cells
por: Sun, Xiaojuan, et al.
Publicado: (2010)

Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis
por: Shi, Changhong, et al.
Publicado: (2014)

Spontaneous Cancer-Stromal Cell Fusion as a Mechanism of Prostate Cancer Androgen-Independent Progression
por: Wang, Ruoxiang, et al.
Publicado: (2012)

Convergent RANK- and c-Met-Mediated Signaling Components Predict Survival of Patients with Prostate Cancer: An Interracial Comparative Study
por: Hu, Peizhen, et al.
Publicado: (2013)

Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high‐risk prostate cancer patients with worse survival following radiation therapy
por: Jacobs, Corbin, et al.
Publicado: (2015)

Targeting Burkitt lymphoma with a tumor cell–specific heptamethine carbocyanine‐cisplatin conjugate
por: Mrdenovic, Stefan, et al.
Publicado: (2019)

β2-Microglobulin-mediated Signaling as a Target for Cancer Therapy
por: Nomura, Takeo, et al.
Publicado: (2014)

Sensitization of radio-resistant prostate cancer cells with a unique cytolethal distending toxin
por: Lai, Chih-Ho, et al.
Publicado: (2014)

Sphingosine Kinase 2 Knockout Mice Resist HFD-Induced Obesity Through Increasing Energy Expenditure
por: Zhao, Jiawei, et al.
Publicado: (2023)

Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients
por: Liu, Shijie, et al.
Publicado: (2016)

Multiplexed Quantum Dot Labeling of Activated c-Met Signaling in Castration-Resistant Human Prostate Cancer
por: Hu, Peizhen, et al.
Publicado: (2011)

The Role of Sphingosine Kinase 1/Sphingosine-1-Phosphate Pathway in the Myogenic Tone of Posterior Cerebral Arteries
por: Lim, Mihwa, et al.
Publicado: (2012)

PDGF Upregulates Mcl-1 Through Activation of β-Catenin and HIF-1α-Dependent Signaling in Human Prostate Cancer Cells
por: Iqbal, Shareen, et al.
Publicado: (2012)

Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease
por: Wang, Bo-Ren, et al.
Publicado: (2022)

Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs
por: Zhou, Jiancheng, et al.
Publicado: (2017)

Cultured circulating tumor cells and their derived xenografts for personalized oncology
por: Wang, Ruoxiang, et al.
Publicado: (2016)

An innovative approach for testing bioinformatics programs using metamorphic testing
por: Chen, Tsong Yueh, et al.
Publicado: (2009)

RANK- and c-Met-mediated signal network promotes prostate cancer metastatic colonization
por: Chu, Gina Chia-Yi, et al.
Publicado: (2014)

KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway
por: Yin, Lijuan, et al.
Publicado: (2022)

Histone lysine demethylase KDM4B regulates the alternative splicing of the androgen receptor in response to androgen deprivation
por: Duan, Lingling, et al.
Publicado: (2019)

Interaction of microRNAs with sphingosine kinases, sphingosine-1 phosphate, and sphingosine-1 phosphate receptors in cancer
por: Xu, Guangmeng, et al.
Publicado: (2021)

A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models
por: Mrdenovic, Stefan, et al.
Publicado: (2023)

The role of microRNAs in prostate cancer progression
por: Lo, U-Ging, et al.
Publicado: (2013)

Detection of Live Circulating Tumor Cells by a Class of Near-Infrared Heptamethine Carbocyanine Dyes in Patients with Localized and Metastatic Prostate Cancer
por: Shao, Chen, et al.
Publicado: (2014)

The efficacy of immediate versus delayed antibiotic administration on bacterial growth and biofilm production of selected strains of uropathogenic Escherichia coli and Pseudomonas aeruginosa
por: Gandee, Leah, et al.
Publicado: (2015)

LIV-1 Promotes Prostate Cancer Epithelial-to-Mesenchymal Transition and Metastasis through HB-EGF Shedding and EGFR-Mediated ERK Signaling
por: Lue, Hui-Wen, et al.
Publicado: (2011)

Exosomes in cancer development and clinical applications
por: Tai, Yu‐Ling, et al.
Publicado: (2018)

Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia
por: Hsu, Shih-Chang, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vtfuitib4t3dt3pe2g6crb1lrv